Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 518B (ZNF518B) is a DNA-binding transcription factor and chromatin regulator containing three zinc finger domains. It participates in chromatin silencing by recruiting and interacting with histone methyltransferase complexes such as G9A (EHMT2) and EZH2, promoting repressive histone modifications (H3K9 and H3K27 methylation) at specific genomic loci. ZNF518B is involved in establishment of heterochromatin at pericentromeric regions, where it interacts with centromere protein B (CENP-B), HP1, and G9A, thus modulating chromosome segregation and stability[1][2][7]. Up-regulation of ZNF518B is observed in colorectal cancer and supports cellular dissemination and metastasis. Genetic variants are linked to gout and diabetes biomarker studies[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 518B (ZNF518B).